91 related articles for article (PubMed ID: 23630429)
1. An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco.
Shihabi AR; Moussa EM; Sobierajska H; Schmidt B
Diabetes Metab Syndr Obes; 2013; 6():141-50. PubMed ID: 23630429
[TBL] [Abstract][Full Text] [Related]
2. International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus.
Li C; Hung YJ; Qamruddin K; Aziz MF; Stein H; Schmidt B
Diabetes Res Clin Pract; 2011 Apr; 92(1):57-64. PubMed ID: 21251726
[TBL] [Abstract][Full Text] [Related]
3. A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.
Zhang W; Kim D; Philip E; Miyan Z; Barykina I; Schmidt B; Stein H;
Clin Drug Investig; 2013 Apr; 33(4):263-74. PubMed ID: 23435929
[TBL] [Abstract][Full Text] [Related]
4. Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.
Philip E; Sundaram ML; Das R; Chauhan SK; Deshpande S; Ambhore S; Rathod R; Manjrekar P
Indian J Endocrinol Metab; 2013 Dec; 17(Suppl 3):S674-9. PubMed ID: 24910836
[TBL] [Abstract][Full Text] [Related]
5. Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China.
Pan CY; Landen H
Clin Drug Investig; 2007; 27(6):397-405. PubMed ID: 17506590
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
Sieradzki J; Soszyński P
Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus. A model of medicine-based evidence.
Scorpiglione N; Belfiglio M; Carinci F; Cavaliere D; De Curtis A; Franciosi M; Mari E; Sacco M; Tognoni G; Nicolucci A
Eur J Clin Pharmacol; 1999 Jun; 55(4):239-49. PubMed ID: 10424314
[TBL] [Abstract][Full Text] [Related]
8. Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes.
Mughal MA; Memon MY; Zardari MK; Tanwani RK; Ali M
J Pak Med Assoc; 2000 May; 50(5):152-6. PubMed ID: 11242714
[TBL] [Abstract][Full Text] [Related]
9. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
10. Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis.
Kalra S; Sahay RK; Schnell O; Sheu WH; Grzeszczak W; Watada H; Soegondo S; Yamamoto N; Weng J; Rathod R
Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S307-9. PubMed ID: 24251196
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study.
Saboo B; Reddy GC; Juneja S; Kedia AK; Manjrekar P; Rathod R;
Indian J Endocrinol Metab; 2015; 19(1):129-35. PubMed ID: 25593840
[TBL] [Abstract][Full Text] [Related]
12. Long-term improvement of metabolic control by acarbose in type 2 diabetes patients poorly controlled with maximum sulfonylurea therapy.
Bachmann W; Petzinna D; Raptis SA; Wascher T; Westermeier T;
Clin Drug Investig; 2003; 23(10):679-86. PubMed ID: 17535083
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review.
Derosa G; Maffioli P
Clin Ther; 2012 Jun; 34(6):1221-36. PubMed ID: 22560622
[TBL] [Abstract][Full Text] [Related]
14. [Continuous blood glucose monitoring: the acute effect of acarbose on blood glucose variations].
Herrmann BL; Schatz H; Pfeiffer A
Med Klin (Munich); 1998 Nov; 93(11):651-5. PubMed ID: 9872041
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of acarbose treatment in patients with type 2 diabetes mellitus.
Segal P; Eliahou HE; Petzinna D; Neuser D; Brückner A; Spengler M
Clin Drug Investig; 2005; 25(9):589-95. PubMed ID: 17532703
[TBL] [Abstract][Full Text] [Related]
16. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
Soonthornpun S; Rattarasarn C; Thamprasit A; Leetanaporn K
J Med Assoc Thai; 1998 Mar; 81(3):195-200. PubMed ID: 9623011
[TBL] [Abstract][Full Text] [Related]
17. Effect of add-on acarbose to insulin therapy in routine clinical practice.
Klocke KR; Stauch K; Landen H
Clin Drug Investig; 2003; 23(10):621-7. PubMed ID: 17535077
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of acarbose in the treatment of type 2 diabetes: data from a 2-year surveillance study.
Mertes G
Diabetes Res Clin Pract; 1998 Apr; 40(1):63-70. PubMed ID: 9699092
[TBL] [Abstract][Full Text] [Related]
19. Acarbose versus Repaglinide in Diabetes Treatment: A New Appraisal of Two Old Rivals.
Pishdad R; Pishdad P; Pishdad GR
Am J Med Sci; 2020 Apr; 359(4):212-217. PubMed ID: 32200914
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blinded, Double-Dummy, Active-Controlled, and Multiple-Dose Clinical Study Comparing the Efficacy and Safety of Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet and Acarbose in Individuals with Type 2 Diabetes Mellitus.
Li M; Huang X; Ye H; Chen Y; Yu J; Yang J; Zhang X
Evid Based Complement Alternat Med; 2016; 2016():7121356. PubMed ID: 27547230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
